tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

LYEL Stock Latest News

Lyell Immunopharma price target lowered to 60c from $1 at BofA
The FlyLyell Immunopharma price target lowered to 60c from $1 at BofA
7d ago
LYEL
Lyell Immunopharma presents positive data from Phase 1-2 IMPT-314 study
PremiumThe Fly
Lyell Immunopharma presents positive data from Phase 1-2 IMPT-314 study
1M ago
LYEL
Lyell Immunopharma Reports Q3 2024 Financial Results
PremiumCompany Announcements
Lyell Immunopharma Reports Q3 2024 Financial Results
2M ago
LYEL
Lyell Immunopharma reports Q3 net loss $44.6M vs. $50.9M last year
PremiumThe Fly
Lyell Immunopharma reports Q3 net loss $44.6M vs. $50.9M last year
2M ago
LYEL
Is LYEL a Buy, Before Earnings?
PremiumPre-Earnings
Is LYEL a Buy, Before Earnings?
3M ago
LYEL
Buy/Sell: Wall Street’s top 10 stock calls this week
PremiumThe FlyBuy/Sell: Wall Street’s top 10 stock calls this week
3M ago
CE
ARM
Lyell Immunopharma’s Strategic Moves and Leadership Expansion
Premium
Company Announcements
Lyell Immunopharma’s Strategic Moves and Leadership Expansion
3M ago
8K
LYEL
Lyell Immunopharma double downgraded to Underperform at BofA after reorg
Premium
The Fly
Lyell Immunopharma double downgraded to Underperform at BofA after reorg
3M ago
LYEL
Lyell Immunopharma downgraded to Underperform from Buy at BofA
PremiumThe Fly
Lyell Immunopharma downgraded to Underperform from Buy at BofA
3M ago
LYEL
Lyell Immunopharma Acquires ImmPACT Bio to Enhance Pipeline
PremiumCompany Announcements
Lyell Immunopharma Acquires ImmPACT Bio to Enhance Pipeline
3M ago
8K
LYEL
Lyell to acquire ImmPACT Bio, discontinue LYL797 and LYL845 programs
PremiumThe Fly
Lyell to acquire ImmPACT Bio, discontinue LYL797 and LYL845 programs
3M ago
LYEL
Caribou Biosciences Ltp appoims Albertso as CMO
PremiumThe Fly
Caribou Biosciences Ltp appoims Albertso as CMO
5M ago
CRBU
LYEL
Lyell Immunopharma reports Q2 revenue $40.3M vs.$47M last year
PremiumThe FlyLyell Immunopharma reports Q2 revenue $40.3M vs.$47M last year
5M ago
LYEL
Dynatrace initiated, U.S. Bancorp downgraded: Wall Street’s top analyst calls
Premium
The Fly
Dynatrace initiated, U.S. Bancorp downgraded: Wall Street’s top analyst calls
7M ago
A
BB
Lyell Immunopharma price target lowered to $6 from $9 at BofA
Premium
The Fly
Lyell Immunopharma price target lowered to $6 from $9 at BofA
7M ago
LYEL
Lyell Immunopharma downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Lyell Immunopharma downgraded to Neutral from Buy at H.C. Wainwright
7M ago
LYEL
Lyell Immunopharma’s Promising CAR T-Cell Therapy Trial Results
PremiumCompany Announcements
Lyell Immunopharma’s Promising CAR T-Cell Therapy Trial Results
7M ago
8K
LYEL
Lyell Immunopharma announces initial clinical data from Phase 1 trial of LYL797
PremiumThe Fly
Lyell Immunopharma announces initial clinical data from Phase 1 trial of LYL797
7M ago
LYEL
Lyell Immunopharma reports Q1 revenue $3,000 vs $65,000 last year
PremiumThe Fly
Lyell Immunopharma reports Q1 revenue $3,000 vs $65,000 last year
9M ago
LYEL
Lyell Immunopharma files $400M mixed securities shelf
PremiumThe FlyLyell Immunopharma files $400M mixed securities shelf
11M ago
LYEL
Lyell Immunopharma price target lowered to $6 from $8 at H.C. Wainwright
Premium
The Fly
Lyell Immunopharma price target lowered to $6 from $8 at H.C. Wainwright
11M ago
LYEL
Lyell Immunopharma announces Orphan Drug Designation for LYL845
Premium
The Fly
Lyell Immunopharma announces Orphan Drug Designation for LYL845
1y ago
LYEL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >